CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
This article helps you decide between taxable and tax-exempt bond funds in retirement, outlining allocation strategies and tax considerations.
25,011 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
NVIDIA CEO Jensen Huang has framed a $40 trillion TAM for labor automation via robotics, prompting a broader look at ...
ICE launches an Encompass-integrated Fraud Monitor, centralizing fraud risk signals and property data. Early pilots i...
A trader alleges Polymarket unfairly resolved a market tied to MicroStrategy's bitcoin sale, claiming a post-deadline...
As SPIR prepares for 2025, investors want clarity on revenue mix, profitability, and cash flow. This guide breaks dow...
ICP bucked a broad market downturn, edging higher while Bitcoin and Ethereum slumped. On-chain metrics and ecosystem ...
CrowdStrike posted a strong ARR beat and raised guidance, sparking a spirited defense from Jim Cramer as shares softe...
POET Technologies has logged a 220% surge over the past year, but traders are contending with signs of a potential co...
Bernstein analysts say Bitcoin’s ‘boring’ cycle persists and the store-of-value thesis remains intact despite $2.6 bi...
Circle debuted CirBTC on Ethereum, a 1:1 BTC-backed ERC-20 token with real-time reserve proof, targeting institutiona...
XRP is testing a rare monthly RSI low that historians say has preceded big rallies before. Traders weigh the odds as ...
Qualcomm and Arm tumble as the mobile-chip complex sinks on a broader market pullback, underscoring renewed risk-off ...